Sonia Vallabh, PhD

Location: 

Broad Institute of MIT and Harvard

Grant Year: 

2020

 


Prion disease can be effectively treated or delayed in animals by reducing the amount of prion protein in the brain. Recent data indicate that potent, long-lasting reduction of a specific protein in the brain can be achieved by zinc finger proteins (ZFPs) engineered to turn off a gene by binding the DNA and preventing its transcription into RNA. This offers a potential new therapeutic strategy in prion disease. We will test the ability of ZFPs targeting the prion protein gene to lower brain prion protein levels and prevent or treat disease in prion-infected mice.

About the Researcher:

Sonia Vallabh co-runs a prion research laboratory at the Broad Institute of MIT and Harvard along with her husband, Eric Minikel. She earned her PhD in Biological and Biomedical Sciences from Harvard Medical School in 2019. Sonia and Eric left their previous careers to devote their lives to biomedical research after learning in 2011 that Sonia had inherited from her mother a mutation that causes genetic prion disease. At the Broad Institute, Sonia works on prion disease drug discovery, with a focus on lowering the amount of prion protein in the brain. She also works on biomarkers and other tools to enable drugs to be tested for their ability to prevent or delay, as well as treat, prion disease.

Dr. Vallabh is the recipient of: